| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Nov 1, 2010New Tip Capture Feature Enables Controlled Deployment and Precise Placement of Stent Graft During Minimally Invasive Procedure to Repair Body's Main Artery
MINNEAPOLIS, Nov 01, 2010 (BUSINESS WIRE) -- Advancing the minimally invasive treatment of aortic aneurysms, Medtronic, Inc. (NYSE: MDT), today announced approval by the U.S. Food and Drug...
-
Nov 1, 2010
MINNEAPOLIS, Nov 18, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE: MDT), the leader in spinal cord stimulation for more than 25 years, today announced U.S. Food and Drug Administration (FDA)...
-
Oct 29, 2010
MINNEAPOLIS, Oct 29, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced the U.S. Food and Drug Administration (FDA) has classified the company's previous action related to the...
-
Oct 21, 2010Kyphon Xpander(TM) II Inflatable Bone Tamp Is Latest Innovation in Minimally Invasive Treatment of Spinal Fractures
MINNEAPOLIS, Oct 21, 2010 (BUSINESS WIRE) -- Medtronic Inc. (NYSE:MDT) today announced Food and Drug Administration (FDA) clearance of the Kyphon Xpander II Inflatable Bone Tamp (IBT) for the...
-
Oct 15, 2010Investigational Transcatheter Aortic Valve Implantation System Part of Medtronic's Growing Portfolio for U.S. Patients with Severe Aortic Stenosis
MINNEAPOLIS, Oct 15, 2010 (BUSINESS WIRE) -- Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE)...